Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-20

Clinical Trial Update: Testosterone Effects on Pelvic Floor Muscles [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating testosterone effects on pelvic floor muscles for urinary incontinence and menopause has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Urinary Incontinence, Menopause | Phase 3 | Status: WITHDRAWN